57
report
Strengthening the Biomedical Innovation Ecosystem: A Scorecard for System Assessment
As patients, we often evaluate our interactions within the "system" of biomedical innovation with a
simple question: "Did it work for me?" This evaluation considers many issues, including whether the best treatments are accessible and available, how the
+ Read More
report
Cell and Gene Therapies: Looking Ahead to 2022
Cell and gene therapies are a new category of medicines transforming how we treat and potentially c
ure disease. Both cell and gene therapies seek to modify genetic material to fight disease.
+ Read More
report
Policy Issue Brief: A Call to Action for Diversity in Clinical Trials
FasterCures has initiated a body of work to advance system change within biomedical research to foc
us on and value diversity and representation within clinical trials.
+ Read More
report
Models for Financing Antibiotic Development to Address Antimicrobial Resistance
The Financial Innovations Labs® and FasterCures teams have collaborated on a project to id
report
Clinical Developments in Follicular Lymphoma
Follicular lymphoma (FL) is a rare, slow-growing cancer that affects certain blood cells. People ex
periencing this form of non-Hodgkin lymphoma face multiple relapses over the course of their disease, which can run for years and sometimes decades.
+ Read More
report
New Models for Financing Translational Medical Research in Singapore: Update
Since 2017, the Milken Institute has engaged with stakeholders worldwide on new models for financin
g translational biomedical research in Singapore.
+ Read More
report
Community-Based Infrastructure for Inclusive Research: Engaging the Private Sector
Clinical trial networks, as evidenced during the COVID-19 pandemic, really are “national critical i
nfrastructure.” The pandemic revealed prominent gaps and stark differences in health outcomes across various populations.
+ Read More
report
Building Community-Based Infrastructure for Inclusive Research: Lessons from the Pandemic for Federal Action
COVID-19 has focused the public’s attention on the racial and ethnic disparities in health outcomes
, unequal access to health care, and some communities’ lack of trust and participation in medical research.
+ Read More
report
Coalition-Building between the US and China on Women’s Cancer Detection, Treatment, and Care
Cancer is one of the leading causes of death in the US and China. Of the top 10 (by incidence) canc
ers in China, four are women’s cancers, including breast and cervical cancers.
+ Read More
report
Employer Investments in Digital, Whole-Person Health for Substance Use Disorders
Employers seek to support their employees while normalizing a whole-person approach to substance us
e disorders (SUD). The response to addiction and the opioid crisis requires a whole-of-society approach, including employers of all sizes.
+ Read More
report
Toward a National Action Plan for Achieving Diversity in Clinical Trials
Participation in clinical research among racial and ethnic minorities remains low, even though such
groups now represent nearly 40 percent of the US population.
+ Read More
video
Post-Pandemic Recovery: Global Health and the Economy
October 18 at 8:00 am PDT/11:00 am EDT
The 2021 Milken Institute Global Conference will open with
welcoming remarks from Milken Institute CEO, Michael Klowden, followed by a presentation from Harris Poll CEO, John Gerzema on the release of The
+ Read More